GE HealthCare announced today that it expanded its relationship with Elekta with more collaboration on software for radiation oncology. Together, the companies aim to accelerate innovation in software to improve workflows, increase throughput and enhance user experience. They expect to enable greater precision in radiation therapy treatment with less time at the hospital for patients. […]
Oncology
FDA approves Lumicell’s breast cancer visualization system
Lumicell today announced it received FDA approval for its LumiSystem direct visualization system for breast cancer removal. According to the company, the LumiSystem allows surgeons to scan the breast cavity post-lumpectomy in real time to detect and resect residual cancer that could have been missed with 84% diagnostic accuracy. The LumiSystem with the company’s LumiSight […]
Noah Medical has positive robotic bronchoscopy data
Noah Medical today announced new field data detailing early experience using its Galaxy system for robotic-navigated bronchoscopy. Dr. D. Kyle Hogarth (University of Chicago Medical Center) and Dr. Amit Mahajan (Inova Fairfax Hospital) provided the field data. It represents the findings from 165 total patient procedures investigating 190 total lesions. Key findings include diagnostic yield […]
Exact Sciences names Aaron Bloomer as CFO
Exact Sciences (Nasdaq:EXAS) today announced it appointed Aaron Bloomer as chief financial officer, effective May 15. Bloomer has more than 15 years of finance and accounting experience. Prior to joining the Madison, Wisconsin-based cancer screening and diagnostic company, Bloomer held various leadership roles at Baxter and 3M where he helped improve financial results, drove operations rigor […]
European Commission says Illumina can move forward with Grail divestiture
Illumina (Nasdaq:ILMN) announced today that it received approval of its plan to divest Grail from the European Commission (EC). In September 2020, Illumina announced an agreement to acquire Grail, a DNA sequencing and array-based tech developer. Grail itself was a startup that initially spun out from the company in 2016. Illumina completed the acquisition in August […]
Illumina CFO departs, replacement named along with chief strategy officer
Illumina (Nasdaq:ILMN) announced that it appointed Ankur Dhingra as CFO following the departure of Joydeep Goswami. The company also announced the appointment of Jakob Wedel as chief strategy and corporate development officer. Its c-suite continues to undergo a makeover following the appointment of a new CEO last year amid its long-running battle to acquire Grail. Goswami, […]
Medtronic unveils next-gen GI Genius software, partners with ModMed on AI-powered colonoscopy
Medtronic today announced advancements for its AI-powered GI Genius system, as well as a new collaboration. The company unveiled its ColonPRO latest-generation software for the GI Genius intelligent endoscopy system. GI Genius, a computer-aided polyp detection system powered by AI, has been available in the U.S. since 2021. Medtronic designed it to redefine GI screening by […]
RefleXion inks AI partnership for cancer treatment planning
RefleXion Medical announced today that it signed a licensing agreement with Limbus AI to incorporate software into radiation treatment planning. The agreement enables the integration of the Limbus Contour automated contour software into the RefleXion X1 system. X1 uses biology-guided radiotherapy (BgRT) technology. It enables a PET radiotracer to create a unified motion management solution […]
Delcath Systems announces $7M private placement
Delcath Systems (Nasdaq:DCTH) announced today that it entered into a securities purchase agreement worth $7 million in proceeds. The company entered into an agreement with certain accredited investors for the private placement. The collection of investors includes existing investors, Delcath executives and members of the board of directors. Delcath plans to issue and sell 876,627 […]
SafeGuard Surgical wins FDA breakthrough nod for biodegradable stent backed by NFL QB
SafeGuard Surgical announced today that the FDA granted breakthrough device designation to its LeakGuard biodegradable stent. Along with the regulatory milestone, the company announced that it completed its Series A funding round. Tom Pepin, principal at Tapper Ventures, led the financing. NFL quarterback Jameis Winston is also one of the first investors in the company. […]
Autonomix completes first procedures in pancreatic cancer ablation trial
Autonomix Medical announced today that it completed the first three patient procedures in a proof-of-concept trial of its ablation technology. The Woodlands, Texas-based Autonomix designed its transvascular radiofrequency (RF) ablation technology to treat pancreatic cancer pain. Current approaches to treat this pain include opioids or ethanol injections. However, Autonomix says those approaches may only provide […]